tiprankstipranks
Vext Science (TSE:VEXT)
:VEXT
Canadian Market
Want to see TSE:VEXT full AI Analyst Report?

Vext Science (VEXT) Earnings Dates, Call Summary & Reports

19 Followers

Earnings Data

Report Date
Aug 26, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
>-0.01
Last Year’s EPS
-0.01
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 21, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call communicated clear, measurable operational and financial improvements—strong revenue and gross-profit expansion, a notable narrowing of net loss, positive operating cash flow, and accelerating retail momentum in Ohio. Management also articulated decisive strategic action to exit low-return Arizona cultivation, reducing a material cash and margin drag. Material risks remain, including significant compression in Arizona wholesale, a ~50% drop in consolidated wholesale revenue, a $10.6M uncertain tax liability, and rising competition/price pressure in Ohio alongside capital and permitting needs. On balance, the company demonstrated that its growth and margin initiatives are working and that the negatives are being actively managed and expected to improve over the coming quarters.
Company Guidance
The company guided to continued execution in 2026 focused on scaling Ohio and completing the Eloy cultivation exit in Arizona, with specific targets and financial impacts: Q1 revenue was $12.2M (up 5.2% YoY) with Ohio revenue $8.2M (up 34% YoY) and Arizona down 24%; wholesale fell ~50% to $1.7M; gross profit rose to $5.5M (45.4% margin) and gross profit before fair value was $4.4M (35.8%); adjusted EBITDA was $3.6M (29.3% margin) and net loss narrowed to $0.9M (vs $3.3M prior); cash from operations was $1.6M (13% cash flow margin) and cash was ~$5.5M (vs $5.1M); the uncertain tax position was $10.6M (up $2.5M from $8.1M); operational guidance includes opening the 6th Ohio store (Fairfield) in Q2 2026 and the 7th in Columbus later in 2026 (8th advancing into early 2027), expected ramp times of ~1–1.5 months for Fairfield and ~3–4 months for Columbus, Jeffersonville and Athens coming online within weeks to ~45 days, CapEx of ~$3.0–3.2M for Columbus and ~$2.0–2.5M for the 8th store, completion of the Eloy shutdown by end of Q2 with full cash benefits expected in Q3, expectation of improving operating leverage, margin expansion and cash flow through the year, Ohio cultivation yields up ~15% in Q1 with further Q2 improvement expected, and a shift to sourcing wholesale at roughly $400–$500/lb (with opportunistic sub-$400 buys) versus prior Arizona internal costs of ~$800–$900/lb.
Consolidated Revenue Growth
Revenue for Q1 2026 was $12.2 million, up ~5.2% year-over-year, driven by retail strength in Ohio which more than offset weakness in Arizona.
Material Gross Profit and Margin Expansion
Gross profit more than doubled to $5.5 million with a gross margin of 45.4% in Q1 2026 versus $2.3 million (19.7%) in the prior-year period; gross profit before fair value adjustments was $4.4 million (35.8% margin) versus $4.0 million (34.0%) prior-year.
Strong Adjusted EBITDA and Margin Improvement
Adjusted EBITDA was $3.6 million with a 29.3% margin in Q1 2026, improving from $2.1 million (15% margin) in Q4 2025 and comparable to prior-year Q1 adjusted EBITDA ($3.4M, ~29.6%).
Net Loss Narrowed Significantly
Net loss narrowed to $0.9 million in Q1 2026 from a $3.3 million loss in Q1 2025—an improvement of approximately $2.4 million, or ~73%.
Positive Operating Cash Flow Despite Headwinds
Cash from operations was $1.6 million in Q1 2026 (cash flow margin 13%), and ending cash increased to ~$5.5 million from ~$5.1 million at year-end 2025, demonstrating ongoing cash generation while executing strategic transitions.
Ohio: Primary Growth Driver and Retail Expansion
Ohio revenue increased 34% year-over-year to $8.2 million; statewide Ohio sales (2-month data through Feb) increased >20% YoY. Company expects to open the 6th dispensary (Fairfield) in Q2 2026, 7th in Columbus later in 2026, and advance an 8th license into early 2027, with emphasis on drive-thru capability.
Cultivation Yield Improvements and Sourcing Cost Advantage
Ohio cultivation yields improved almost 15% in Q1 2026 with further strong improvement expected in Q2; company expects to opportunistically source wholesale product at ~ $400–$500 per pound (and occasionally < $400), versus previous internal Arizona cultivation all-in costs of ~$800–$900 per pound.
Strategic De-risking of Arizona Cultivation
Management executed a decisive exit from the Eloy cultivation facility (final harvest in early May) expecting completion of the cultivation exit by end of Q2 2026, refocusing Arizona on two Phoenix Metro dispensaries and light manufacturing to reduce operating costs and improve margin/cash flow profile.

Vext Science (TSE:VEXT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:VEXT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 26, 2026
2026 (Q2)
>-0.01 / -
-0.014
May 21, 2026
2026 (Q1)
- / -
-0.014
Apr 29, 2026
2025 (Q4)
-0.01 / 0.00
-0.014
Nov 20, 2025
2025 (Q3)
>-0.01 / -0.01
-0.0140.00% (0.00)
Aug 20, 2025
2025 (Q2)
-0.01 / -0.01
-0.0140.00% (0.00)
May 21, 2025
2025 (Q1)
- / -
-0.042
Mar 31, 2025
2024 (Q4)
-0.02 / -0.01
-0.04266.67% (+0.03)
Nov 21, 2024
2024 (Q3)
-0.01 / -0.01
-0.0140.00% (0.00)
Aug 20, 2024
2024 (Q2)
-0.01 / -0.01
0.006-350.00% (-0.02)
May 29, 2024
2024 (Q1)
- / -
0
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:VEXT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 21, 2026
C$0.28C$0.28+1.82%
Apr 29, 2026
C$0.28C$0.32+14.29%
Nov 20, 2025
C$0.26C$0.25-1.96%
Aug 20, 2025
C$0.26C$0.27+5.88%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Vext Science (TSE:VEXT) report earnings?
Vext Science (TSE:VEXT) is schdueled to report earning on Aug 26, 2026, TBA (Confirmed).
    What is Vext Science (TSE:VEXT) earnings time?
    Vext Science (TSE:VEXT) earnings time is at Aug 26, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:VEXT EPS forecast?
          TSE:VEXT EPS forecast for the fiscal quarter 2026 (Q2) is >-0.01.